课题基金 / 基金详情

Development of Gene Targeting Technique Using Radiolabeled Antisense DNA

Development of Gene Targeting Technique Using Radiolabeled Antisense DNA
使用放射性标记反义 DNA 开发基因打靶技术
批准号:
10470194
负责人:
TONAMI Norihisa
金额:
$3.39万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

TONAMI Norihisa的其他基金

相似基金

相关文献

中文摘要
翻译
利用放射性标记的反义寡核苷酸(DNA),可以用伽马照相机对扩增mRNA的病变进行成像。这种方法需要适合于寡核苷酸的稳定的放射性金属螯合物。我们建立了裸鼠异种移植肿瘤细胞表达p糖蛋白(P-gp)的体内模型系统。为了成像P-gp引起的多药耐药肿瘤,我们设计了编码P-gp的mdr1基因的15mer反义DNA序列。用巯基修饰寡核苷酸的5′端,反应马来酰氨基- c6 -苄基- edta螯合物。最终产物经ODS色谱鉴定为目的化合物。有必要进一步调查。像寡核苷酸这样的小分子往往会很快从血液中清除,因此,肿瘤对这种示踪剂的绝对摄取是有限的。我们试图通过改变肿瘤组织的递送系统来增加肿瘤对放射性标记抗体的吸收。血管紧张素- ii以2μg/kg/min持续输注,与肌动酶抑制剂马来酸依那普利30 μg联合使用,使小鼠血压由95/61提高到153/67。在正常器官分布变化不大的情况下,肿瘤摄取增加了1.62倍。放射自显像显示,由于血管床再通和血管通透性增加,放射标记抗体在肿瘤中的分布更为均匀。综上所述,通过控制肿瘤组织的血流动力学和血管通透性可以增强肿瘤的摄取,该技术可以应用于小分子的寡核苷酸。
英文摘要
Using radiolabeled antisense oligonucletides (DNA), lesions of amplified mRNA can be imaged with gamma cameras. For this approach, the stable radiometal chelates, which are appropriate for oligonucletide, is required. We have developed the in vivo model system where nude mice xenografted tumor cells express P-glycoprotein (P-gp). To image multidrug resistant tumors caused by P-gp, we designed the 15mer of antisense DNA sequence for the mdr1 gene coding P-gp. The 5'-end of the oligonucletide was modified with the thiol group and the maleimido-C6-benzyl-EDTA chelate was reacted. The final product was identified as the objective compound by ODS chromatography. Further investigation was warranted. The small molecules like oligonucleotides tend to be cleared very rapidly from the blood and therefore, the absolute tumor uptake of this kind of the tracer is limited. We have tried to increase the tumor uptake of radiolabeled antibodies by modifying the delivery system to the tumor tissue. The combination usage of angiotensin-II, continuously infused at 2μg/kg/min, and a kininase inhibitor, enalapril maleate, 30 μg increased the mouse blood pressure from 95/61 to 153/67. And the tumor uptake was also increased by the factor of 1.62 with little change in normal organ distribution. The autoradiography showed that more homogeneous distribution of the radiolabeled antibody in the tumor because of recanalization of vascular beds and increased vascular permeability. In conclusions, enhanced tumor uptake was achieved by manipulating hemodynamics and vascular permeability of the tumor tissue and this technique can be applied for smaller molecule as the oligonucleotides.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Seigo Kimuya: "Euhanced efficacy of vadioimmunotherapy condicred with systemic chemotherapy and local hypothermia in xengraft model."JpnJ.Cancer Res. 91(5). 573-578 (2000)
Seigo Kimuya:“在异种移植模型中,血管免疫疗法的疗效与全身化疗和局部低温一致。”JpnJ.Cancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
横山邦彦: "がんのアイソトープ内用療法" 癌と化学療法. 26(6). (1999)
横山邦彦:“癌症同位素疗法”《癌症与化疗》26(6)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
横山邦彦: "がんのラジオアイソトープ内用療法の利用の現状と展望"Isotope News. 5. 2-7 (1999)
Kunihiko Yokoyama:“使用体内放射性同位素治疗癌症的现状和前景”《同位素新闻》5. 2-7 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Seigo Kinuya: "Early response of tumour to radiotherapy should be apsesaed by both uptake and retention of single photon tracers"Nuclear Medicate Communication. 20(7). 581-588 (1999)
Seigo Kinuya:“肿瘤对放射治疗的早期反应应该通过单光子示踪剂的吸收和保留来实现”核药物通讯。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 8 条
    Application of Radiolabeled Monoclonal A7 Antibody for Radioimmunotherapy of Human Colon Cancer
    • 批准号:
      13470180
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.89万
    • 财政年份:
      2001
    • 负责人:
      TONAMI Norihisa
    • 依托单位:
    Development of Gene Imaging Technique Using Radiolabeled Antisense DNA
    • 批准号:
      08457241
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.58万
    • 财政年份:
      1996
    • 负责人:
      TONAMI Norihisa
    • 依托单位:
    Judgment of chemotherapeutic effecrs on the viability of malignant bone tumors with T1-201SPECT
    • 批准号:
      06670910
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $0.64万
    • 财政年份:
      1994
    • 负责人:
      TONAMI Norihisa
    • 依托单位:
    国内基金
    海外基金
    靶向 TTR 的新型 Oligonucleotide-GalNAc 偶联物的高效构建与设计
    地氟醚预处理对内皮细胞缺氧/复氧损伤影响分子网络调控机制
    • 批准号:
      30972838
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2009
    • 负责人:
      朱彪
    • 依托单位:
    oligonucleotide探针及弗氏菌根际生态的研究